Inhibition of p38 MAPK reduces expression of vascular endothelial growth factor in allergic airway disease

Journal of Clinical Immunology

Volumn 32, Issue 3, 2012, Pages 574-586

  Kim, So Ri ^a   Lee, Kyung Sun ^a   Park, Seoung Ju ^a   Jeon, Myung Shin ^a   Lee, Yong Chul ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Asthma; p38 MAPK; SB 239063; vascular permeability; VEGF

Indexed keywords

4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; CBO P 11; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; OVALBUMIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BINDING AFFINITY; BLOOD VESSEL PERMEABILITY; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EOSINOPHIL COUNT; EXTRAVASATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOREACTIVITY; INFLAMMATORY CELL; LUNG LAVAGE; LYMPHOCYTE COUNT; MOLECULAR PATHOLOGY; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TH2 CELL;

ALLERGENS; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTHELIAL GROWTH FACTORS; FEMALE; IMIDAZOLES; IMMUNOGLOBULIN E; MICE; MICE, INBRED C57BL; OVALBUMIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDES, CYCLIC; PROTEIN KINASE INHIBITORS; PYRIMIDINES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862812798     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-012-9672-5     Document Type: Article

References (41)

1. Chetta A, Zanini A, Foresi A, Del Donno M, Castagnaro A, D'Ippolito R, et al. Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone. Am J Respir Crit Care Med. 2003;167:751-7. (Pubitemid 36801754)
2. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000;61:1720-45. (Pubitemid 30329053)
3. Wilson J. The bronchial microcirculation in asthma. Clin Exp Allergy. 2000;30:51-3. (Pubitemid 30341379)
4. DvorakHF, BrownLF, DetmarM, DvorakAM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995;146:1029-39.
5. Lee KS, Kim SR, Park SJ, Lee HK, Park HS, Min KH, et al. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) reduces vascular endothelial growth factor expression in allergen-induced airway inflammation. Mol Pharmacol. 2006;69:1829-39.
6. Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V, et al. Vascular endothelial growth factor (VEGF) induces remodelingand enhances TH2-mediated sensitization and inflammation in the lung. Nat Med. 2004;10:1095-103. (Pubitemid 39424871)
7. Asai K, Kanazawa H, Otani K, Shiraishi S, Hirata K, Yoshikawa J. Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects. J Allergy Clin Immunol. 2002;110:571-5. (Pubitemid 35178791)
8. Lee KS, Kim SR, Park HS, Jin GY, Lee YC. Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression. J Allergy Clin Immunol. 2004;114:1093-9. (Pubitemid 39469149)
9. Schaeffer HJ, Weber MJ. Mitogen-activated protein kinases: specific messages from ubiquitous messengers.Mol Cell Biol. 1999;19:2435-44. (Pubitemid 29144487)
10. Griswold DE, Young PR. Pharmacology of cytokine suppressive anti-inflammatory drug binding protein (CSBP), a novel stress-induced kinase. Pharmacol Commun. 1996;7:323-9. (Pubitemid 27016247)
11. Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: An update. Pharmacol Rev. 1998;50:515-96. (Pubitemid 29028812)
12. Kumar A, Lnu S, Malya R, Barron D, Moore J, Corry DB, et al. Mechanical stretch activates nuclear factor-kappaB, activator protein-1, and mitogen-activated protein kinases in lung parenchyma: implications in asthma. FASEB J. 2003;17:1800-11. (Pubitemid 37214774)
13. Taube C, Nick JA, Siegmund B, Duez C, Takeda K, Rha YH, et al. Inhibition of early airway neutrophilia does not affect development of airway hyperresponsiveness. Am J Respir CellMol Biol. 2004;30:837-43. (Pubitemid 38736908)
14. Underwood DC, Osborn RR, Kotzer CJ, Adams JL, Lee JC, Webb EF, et al. SB 239063, a potent p38 MAP kinase inhbitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J Pharmacol Exp Ther. 2000;293:281-8. (Pubitemid 30180950)
15. Duan W, Chan JH, McKay K, Crosby JR, Choo HH, Leung BP, et al. Inhaled p38a mitogen activated protein kinase antisense oligonucleotide attenuates asthma in mice. Am J Respir Crit Care Med. 2005;171:571-8. (Pubitemid 40365411)
16. Foltz IN, Lee JC, Young PR, Schrader JW. Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway. J Biol Chem. 1997;27:3296-301. (Pubitemid 27066822)
17. Kwak YG, Song CH, Yi HK, Hwang PH, Kim JS, Lee KS, et al. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest. 2003;111:1083-92. (Pubitemid 36397485)
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-9. (Pubitemid 17064313)
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-8. (Pubitemid 34164012)
20. Tournoy KG, Kips JC, Schou C, Pauwels RA. Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness. Clin Exp Allergy. 2000;30:79-85. (Pubitemid 30093884)
21. Takeda K, Hamelmann E, Joetham A, Shultz LD, Larsen GL, Irvin CG, et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med. 1997;186:449-54. (Pubitemid 27332903)
22. Wong WF. Inhibitors of the tyrosine kinase signaling cascade for asthma. Curr Opin Pharmacol. 2005;5:264-71.
23. Lee JC, Kumar S, Griswold DE, Underwood DC, Votta BJ, Adams JL. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology. 2000;47:185-201. (Pubitemid 30394538)
24. Howard MO, Schwartz LW, Newton JF, Qualls Jr CW, Yodis LA, Ventre JR. Comparative biochemical and morphometric changes associated with induction of the hepatic mixed function oxidase system in the rat. Toxicol Pathol. 1991;19:115-22.
25. Adams JL, Boehm JC, Kassis S, Gorycki PD, Webb EF, Hall R, et al. Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes. Bioorg Med Chem Lett. 1998;8:3111-6. (Pubitemid 28551630)
26. Laufer SA, Wagner GK, Kotschenreuther DA, Albrecht W. Novel substituted pyridinyl imidazoles as potent anticytokine agents with low activity against hepatic cytochrome P450 enzymes. J Med Chem. 2003;46:3230-44. (Pubitemid 36849601)
27. Barone FC, Irving EA, Ray AM, Lee JC, Kassis S, Kumar S, et al. SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J Pharmacol Exp Ther. 2001;296:312-21. (Pubitemid 32112455)
28. Marshall LA, Hansbury MJ, Bolognese BJ, Gum RJ, Young PR, Mayer RJ. Inhibitors of the p38 mitogen-activated kinase modulate IL-4 induction of low affinity IgE receptor (CD23) in human monocytes. J Immunol. 1998;161:6005-13. (Pubitemid 28535969)
29. Bracke M, Coffer PJ, Lammers JW, Koenderman L. Analysis of signal transduction pathways regulating cytokine-mediated Fc receptor activation on human eosinophils. J Immunol. 1998;161:6768-74. (Pubitemid 28562220)
30. Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond). 2005;109:227-41. (Pubitemid 41337127)
31. Issbrücker K, Marti HH, Hippenstiel S, Springmann G, Voswinckel R, Gaumann A, et al. p38 MAP kinase-a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB J. 2003;17:262-4.
32. Kevil CG, Payne DK, Mire E, Alexander JS. Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J Biol Chem. 1998;273:15099-103. (Pubitemid 28272806)
33. Yoshino Y, Aoyagi M, Tamaki M, Duan L, Morimoto T, Ohno K. Activation of p38 MAPK and/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells. Int J Oncol. 2006;29:981-7.
34. Meng Q, Wang W, Fang C, Lv Z, Fan Y, An Y, et al. IL-25 and Its Receptor (IL-25R) in Allergic Inflammation: Its Role in VEGF-mediated Angiogenesis. J Allergy Clin Immunol. 2009;123:S58.
35. Nissim Ben Efraim AH, Puxeddu I, Eliashar R, Levi-Schaffer F. Hypoxia Modulates Human Eosinophils Signalling and Function. J Allergy Clin Immunol. 2009;123:S53.
36. Leigh R, OyelusiW,Wiehler S, Koetzler R, Zaheer RS, Newton R, et al. Human rhinovirus infection enhances airway epithelial cell production of growth factors involved in airway remodeling. J Allergy Clin Immunol. 2008;121:1238-45.
37. Lee KS, Kim SR, Park SJ, Msin KH, Lee KY, Choe YH, et al. Mast cells can mediate vascular permeability through regulation of the PI3K-HIF-1alpha-VEGF axis. Am J Respir Crit Care Med. 2008;178:787-97.
38. Lee YC, Kwak YG, Song CH. Contribution of vascular endothelial growth factor to airway hyper-responsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Immunol. 2002;168:3595-600. (Pubitemid 34250430)
39. Horiuchi H, Weller PF. Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony stimulating factor and interleukin-5. Am J Respir Cell Mol Biol. 1997;17:70-7. (Pubitemid 127500822)
40. Taichman NS, Young S, Cruchley AT, Taylor P, Paleolog E. Human neutrophils secrete vascular endothelial growth factor. J Leukocyte boil. 1997;62:397-400.
41. Hoshino M, Nakamura Y, Hamid QA. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol. 2001;107:1034-8. (Pubitemid 32523344)